{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:01:27Z","timestamp":1774432887843,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114209","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T22:18:14Z","timestamp":1738880294000},"page":"114209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fluorofenidone mitigates liver fibrosis through GSK-3\u03b2 modulation and hepatocyte protection in a 3D tissue-engineered model"],"prefix":"10.1016","volume":"149","author":[{"given":"Long","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-3661","authenticated-orcid":false,"given":"Min","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.114209_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12072-019-09997-6","article-title":"TAF and TDF attenuate liver fibrosis through NS5ATP9, TGF\u03b21\/Smad3, and NF-\u03baB\/NLRP3 inflammasome signaling pathways","volume":"14","author":"Zhao","year":"2020","journal-title":"Hepatol Int."},{"issue":"5","key":"10.1016\/j.intimp.2025.114209_b0010","doi-asserted-by":"crossref","first-page":"e1188","DOI":"10.1016\/j.cgh.2021.03.019","article-title":"A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis","volume":"20","author":"Fujiwara","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114209_b0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114209_b0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/SHK.0000000000001960","article-title":"Fluorofenidone attenuates pulmonary inflammation and fibrosis by inhibiting the il-11\/mek\/erk signaling pathway","volume":"58","author":"Song","year":"2022","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.intimp.2025.114209_b0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/1574888X17666220614160957","article-title":"Co-culture of Liver Parenchymal Cells with Non-parenchymal Cells Under 2D and 3D Culture Systems; A Review","volume":"18","author":"Farzaneh","year":"2023","journal-title":"Curr Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.114209_b0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/13880209.2022.2110128","article-title":"Kuhuang injection exerts a protective effect by activating PPAR-\u03b3 in an in vitro model of chlorpromazine-induced cholestatic liver injury constructed by tissue engineering","volume":"60","author":"Wu","year":"2022","journal-title":"Pharm Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114209_b0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000329080","article-title":"Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-\u03b2(1)-induced fibroblast activation","volume":"34","author":"Yuan","year":"2011","journal-title":"Am J Nephrol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114209_b0040","first-page":"452","article-title":"Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation","volume":"67","author":"Chen","year":"2012","journal-title":"Pharmazie"},{"issue":"5","key":"10.1016\/j.intimp.2025.114209_b0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/SHK.0b013e31826fe992","article-title":"Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway","volume":"38","author":"Meng","year":"2012","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.intimp.2025.114209_b0050","doi-asserted-by":"crossref","first-page":"G253","DOI":"10.1152\/ajpgi.00471.2012","article-title":"Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells","volume":"306","author":"Peng","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114209_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166556","article-title":"Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk\/-Egr-1 signaling and Tgf\u03b21\/Smad pathway in mice","volume":"1868","author":"Wang","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.114209_b0060","first-page":"2931","article-title":"SK-Hep1: not hepatocellular carcinoma cells but a cell model for liver sinusoidal endothelial cells","volume":"11","author":"Tai","year":"2018","journal-title":"Int J Clin Exp Pathol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114209_b0065","article-title":"Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-\u03b21\/Smad pathway: implications for liver cancer","volume":"28","author":"Peng","year":"2023","journal-title":"PeerJ"},{"issue":"8","key":"10.1016\/j.intimp.2025.114209_b0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jmcb\/mjaa013","article-title":"Progress in human liver organoids","volume":"12","author":"Sun","year":"2020","journal-title":"J Mol Cell Biol."},{"issue":"24","key":"10.1016\/j.intimp.2025.114209_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001517","article-title":"Current Advances on 3D-Bioprinted Liver Tissue Models","volume":"9","author":"Ma","year":"2020","journal-title":"Adv Healthc Mater."},{"issue":"7","key":"10.1016\/j.intimp.2025.114209_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800347","article-title":"3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications","volume":"14","author":"Lauschke","year":"2019","journal-title":"Biotechnol J."},{"key":"10.1016\/j.intimp.2025.114209_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111130","article-title":"Dimethyl fumarate protects against intestinal ischemia\/reperfusion lesion: Participation of Nrf2\/HO-1, GSK-3\u03b2 and Wnt\/\u03b2-catenin pathway","volume":"134","author":"Gendy","year":"2021","journal-title":"Biomed Pharmacother."},{"issue":"25","key":"10.1016\/j.intimp.2025.114209_b0090","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.7150\/thno.47717","article-title":"Glycogen synthase kinase-3\u03b2: a promising candidate in the fight against fibrosis","volume":"10","author":"Zheng","year":"2020","journal-title":"Theranostics."},{"issue":"3","key":"10.1016\/j.intimp.2025.114209_b0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0014-5793(97)01235-0","article-title":"Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1\/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216","volume":"416","author":"Shaw","year":"1997","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.intimp.2025.114209_b0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41401-020-0498-z","article-title":"MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3\u03b2","volume":"42","author":"Yu","year":"2021","journal-title":"Acta Pharmacol Sin."},{"issue":"10","key":"10.1016\/j.intimp.2025.114209_b0105","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.apsb.2021.06.017","article-title":"TRIB3\u2013GSK-3\u03b2 interaction promotes lung fibrosis and serves as a potential therapeutic target","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin b."},{"issue":"8","key":"10.1016\/j.intimp.2025.114209_b0110","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1096\/fj.201701137R","article-title":"Inhibition of GSK-3\u03b2 induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis","volume":"32","author":"Zhuang","year":"2018","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.intimp.2025.114209_b0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41419-021-03709-5","article-title":"Permissive effect of GSK3\u03b2 on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.114209_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108683","article-title":"Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin","volume":"108","author":"Su","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114209_b0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41420-023-01749-8","article-title":"Programmed cell death in hepatic fibrosis: current and perspectives","volume":"9","author":"Lu","year":"2023","journal-title":"Cell Death Discov."},{"issue":"17","key":"10.1016\/j.intimp.2025.114209_b0130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid Redox Signal."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114209_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrfmmm.2009.09.007","article-title":"A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders","volume":"690","author":"Kim","year":"2010","journal-title":"Mutat Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:02:18Z","timestamp":1740618138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"alternative-id":["S1567576925001997"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114209","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorofenidone mitigates liver fibrosis through GSK-3\u03b2 modulation and hepatocyte protection in a 3D tissue-engineered model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114209"}}